Is a complete FRA/1BD research report available?

No complete published report is available for fra/1BD (FRA/1BD) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FRA/1BD (FRA/1BD)

Frankfurt Stock Exchange: FRA/1BD · EUR

€0.31

-0.00 (-1.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-08-01 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FRA/1BD analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	31.9M
Revenue (ttm)	7.6M
Net income (ttm)	-236.4K
EPS (ttm)	-€0.00

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 7.6M
Net income (ttm): -236.4K
EPS (ttm): -€0.00
Market cap: 31.9M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

All FRA/1BD indicators

Market & fundamental data

Available fields

157

Groups with data

Currency

SEK

Showing 157 of 157 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	DE
Employees	33
Employees Change	-3.6%
Employees Change Percent	-12
Enterprise value	EUR 28.1M
Exchange	Frankfurt Stock Exchange
Financial currency	SEK
First seen	2026-05-10
Industry	Medicinal Chemicals and Botanical Products
Last refreshed	2026-08-01
Market cap	EUR 31.9M
Price	EUR 0.31
Price currency	EUR
Rev Per Employee	228,790.42x
Sic	2833
Symbol	fra/1BD
Website	https://www.bio-works.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.74%
EV/Sales	3.73x
FCF yield	-2.74%
P/B ratio	6.36x
P/S ratio	4.23x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-7.84%
EBITDA Margin	-7.22%
Gross margin	75%
Gross Profit	EUR 5.7M
Gross Profit Growth	129.21%
Gross Profit Growth Q	190.35%
Gross Profit Growth3 Y	28.81%
Gross Profit Growth5 Y	22.79%
Net Income	EUR -236,401
Pretax Margin	-5.43%
Profit Margin	-3.13%
Profit Per Employee	EUR -7,164
ROA	-6.42
Roa5y	-28.68
ROCE	-11.8
ROE	-5.67
Roe5y	-57.46
ROIC	-8.87

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	67.8%
Cagr3y	-33.58%
Cagr5y	-28.59%
Revenue Growth	153.27x
Revenue Growth Q	226.5x
Revenue Growth3 Y	24.16x
Revenue Growth5 Y	26.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.31
Assets	EUR 6.4M
Cash	EUR 3.8M
Current Assets	EUR 6.3M
Current Liabilities	EUR 1.4M
Debt	EUR 0
Equity	EUR 5M
Liabilities	EUR 1.4M
Long Term Assets	EUR 155,137
Long Term Liabilities	EUR 100
Net Cash	EUR 3.8M
Net Cash By Market Cap	EUR 11.78
Net Cash Growth	38.82%
Net Debt Equity	EUR -0.75
Tangible Book Value	EUR 5M
Tangible Book Value Per Share	EUR 0.05

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.43
Inventory Turnover	1.5
Net Working Capital	EUR 1.1M
Quick ratio	3.27
Working Capital	EUR 4.9M
Working Capital Turnover	EUR 0.17

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-47.5%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	67.74%
200-day SMA	0.26
3Y total return	-70.7%
50-day SMA	0.31
50-day SMA vs 200-day SMA	50over200
5Y total return	-81.43%
All Time High	2.75
All Time High Change	-88.65%
All Time High Date	2021-12-03
All Time Low	0.04
All Time Low Change	612.33%
All Time Low Date	2024-12-20
ATR	0.02
Ch YTD	51.46
High	0.31
High52	0.41
High52 Date	2026-06-01
High52ch	-24.64%
Low	0.31
Low52	0.18
Low52 Date	2026-07-03
Low52ch	73.33%
Ma50ch	2.16%
Price vs 200-day SMA	18.9%
RSI	55.22
RSI Monthly	48.91
RSI Weekly	54.69
Sharpe ratio	0.94x
Sortino ratio	1.7
Total Return	-47.5%
Tr YTD	51.46
Tr1m	9.47%
Tr1w	10.25%
Tr3m	18.18%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -591,551
Operating margin	-7.84

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	44,841,765%
Shares Insiders	27.97%
Shares Institutions	8.57%
Shares Qo Q	5.07%
Shares Yo Y	47.5%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	41.85x
Bv Per Share	0.05
CAPEX	EUR -46,205
Ch1m	9.47
Ch1w	10.25
Ch1y	67.74
Ch3m	18.18
Ch3y	-70.7
Ch5y	-81.43
Ch6m	17.74
Change	-0.95%
Change From Open	0
Close	0.32
Days Gap	-0.95
Depreciation Amortization	46,289.8
Earnings Date	2026-08-21
EBIT	EUR -591,551
EBITDA	EUR -545,254
EPS	EUR -0
F Score	1
FCF	EUR -875,159
FCF EV Yield	-3.11x
Financing CF	1,931,493
Fiscal Year End	December
Founded	2,006
Income Tax	EUR -173,337
Investing CF	-46,205
Is Primary Listing	0
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Ma150	0.28
Ma150ch	11.11%
Ma20	0.29
Ma20ch	8.15%
Net CF	1,051,412
Next Earnings Date	2026-08-21
Open	0.31
Ppne	154,269
Price Date	2026-07-31
Ptbv Ratio	6.36
Relative Volume	6.64x
Revenue	7,550,084x
Tax By Revenue	-2.3x
Tr6m	17.74%
Z Score	2.93

FRA/1BD (FRA/1BD)

Coverage state: Market snapshot only — no published research

Generate the first FRA/1BD analysis

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/1BD

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All FRA/1BD indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FRA/1BD

Frequently asked questions